GTR00911502

CD16 (C16/1045), CF488A conjugate, 0.1mg/mL

ml-1mg-0

Description

This antibody recognizes CD16 (FcÎ3RIII), the low-affinity receptor for IgG with an apparent molecular weight of 50-80 kDa. Two similar genes represent CD16, CD16A (FcÎ3RIIIA), which exists as a hetero-oligomeric polypeptide-anchored form in macrophages and NK cells and CD16B (FcÎ3RIIIB), which exist as a monomeric GPI-anchored form in neutrophils. Furthermore, there are two known polymorphisms of CD16B, NA-1 and NA-2. Individuals homozygous for NA-2 show a lower phagocytic capacity compared with NA-1. CD16 binds IgG in the form of immune complexes and shows preferential binding of IgG1 and IgG3 isotypes and minimal binding of IgG2 and IgG4. Upon IgG binding, both CD16 isoforms initiate signal transduction cascades that lead to a variety of responses including antibody-dependent cell-mediated cytotoxicity (ADCC), phagocytosis, degranulation and proliferation. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Synonyms
CD162; CLA; Cutaneous lymphocyte associated antigen; P-selectin glycoprotein ligand 1; PSGL1; Selectin P ligand; SELPLG

Description

This antibody recognizes CD16 (FcÎ3RIII), the low-affinity receptor for IgG with an apparent molecular weight of 50-80 kDa. Two similar genes represent CD16, CD16A (FcÎ3RIIIA), which exists as a hetero-oligomeric polypeptide-anchored form in macrophages and NK cells and CD16B (FcÎ3RIIIB), which exist as a monomeric GPI-anchored form in neutrophils. Furthermore, there are two known polymorphisms of CD16B, NA-1 and NA-2. Individuals homozygous for NA-2 show a lower phagocytic capacity compared with NA-1. CD16 binds IgG in the form of immune complexes and shows preferential binding of IgG1 and IgG3 isotypes and minimal binding of IgG2 and IgG4. Upon IgG binding, both CD16 isoforms initiate signal transduction cascades that lead to a variety of responses including antibody-dependent cell-mediated cytotoxicity (ADCC), phagocytosis, degranulation and proliferation. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Related Products

CD62L (L-Selectin) (CD62L/1588), CF488A conjugate, 0.1mg/mL
GTR00908672

CD62L (L-Selectin) (CD62L/1588), CF488A conjugate, 0.1mg/mL

1x 100 µL
$264.92($350.36)
CD7 (T3-3A1), Biotin conjugate, 0.1mg/mL
GTR00909041

CD7 (T3-3A1), Biotin conjugate, 0.1mg/mL

1x 100 µL
$264.92($350.36)
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/2052R), 1mg/mL
GTR00909690

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/2052R), 1mg/mL

1x 50 µL
$492.80($651.73)
CD80 (B7-1) (C80/2723), CF488A conjugate, 0.1mg/mL
GTR00909797

CD80 (B7-1) (C80/2723), CF488A conjugate, 0.1mg/mL

1x 500 µL
$645.08($853.12)